Baril, Maria Fe G.

HRN: 26-17-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CO-AMOXICLAV 625MG (TAB)
05/21/2026
05/27/2026
PO
625mg
Q8h
UTI Following Delivery
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: